Metformin plus antidepressants for depression in obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether adding metformin (a diabetes medicine) to usual antidepressant treatment can help improve depression in people who are overweight or obese. It is for adults age 18–44 who are newly diagnosed with depression and do not have diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 44 years old.
- You have a BMI over 25 (considered overweight or obese).
- You have been newly diagnosed with depression (mild to severe).
- You do not have diabetes, and your blood sugar is in the normal range.
- You have not taken any psychiatric medication in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding metformin to antidepressants helps people who have both depression and obesity. It also looks at genetic factors that might affect treatment response.
This trial tests whether dapagliflozin, a diabetes medication, can help treat major depression. It is for adults who have been depressed for at least 2 months and score high on a depression scale.
This trial tests whether metformin, a common diabetes medicine, can help people with obesity lose weight. It is for people who do not have diabetes and have not used weight loss treatments in the past year.
This trial tests whether the diabetes drug metformin can help people with asthma who are also overweight or obese. The goal is to see if it improves asthma control and reduces the need for rescue medications.
This trial tests whether metformin can help adults with intellectual disability who gained weight from long-term antipsychotic medicines. If you qualify, you may be assigned metformin to improve weight and related health measures.
This trial compares a new drug, TriGlytza-01, to metformin in people with type 2 diabetes who are overweight or obese and whose blood sugar isn't well controlled despite taking metformin. The goal is to see if the new drug works better at improving blood sugar and weight.
Hear when a new Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.